Is NAD+ a Peptide or Something Else?

NAD+ is not a peptide. It's a dinucleotide — nicotinamide adenine dinucleotide, which is where the name comes from — and chemically it belongs to a completely different family of molecules. A peptide is a chain of amino acids joined by peptide bonds; NAD+ has no amino acids and no peptide bonds in its structure. The confusion happens because both get researched and quoted in the same research-supply catalogues, not because they're chemically related.

What exactly is NAD+?

NAD+ is a coenzyme present in every cell. Structurally it's two nucleotides joined at their phosphate groups: one carries an adenine base, the other a nicotinamide base. That nucleotide-to-nucleotide link is what earns it the name dinucleotide.

Its best-studied biological role is as an electron carrier in reduction-oxidation reactions: it switches between its oxidized form (NAD+) and its reduced form (NADH) inside central metabolic pathways, including glycolysis and the mitochondrial electron transport chain. It's also the substrate consumed by enzymes such as sirtuins and PARPs, which is why it shows up so often in the literature on cellular metabolism and aging.

What is a peptide, and how is it different?

A peptide is a short sequence of amino acids — typically between two and fifty — linked by peptide bonds, the same type of bond that holds proteins together, just in shorter chains. The amino acid sequence is what determines a peptide's shape and function.

That's the underlying difference from NAD+:

• A peptide is built from amino acids. NAD+ is built from nucleotides, the same basic units that make up DNA and RNA.
• A peptide has peptide bonds. NAD+ has phosphodiester bonds linking its two nucleotide halves.
• Molecular weight also varies by compound, but the chemical classification doesn't depend on weight — it depends on what kind of units form the molecule and how they're linked.

Compounds like MOTS-c are peptides in the strict sense: a sequence of amino acids encoded in mitochondrial DNA. NAD+, by contrast, isn't even synthesized as an amino acid chain — it's assembled from precursors like tryptophan or nicotinamide through a metabolic pathway entirely separate from peptide synthesis.

Why are they quoted in the same catalogue, then?

Because within laboratory research — cellular longevity, mitochondrial biology, metabolism — NAD+ and several research peptides get cited in the same papers and studied with the same experimental models. Research supplier catalogues tend to group together whatever a given lab might need for one line of work, without that implying the molecules share a chemical classification.

It's the same pattern you see across the catalog of research compounds: peptides, dinucleotides and other biomolecules sit side by side because they answer to the same research demand, not because they're chemically equivalent.

What does the scientific literature study about NAD+?

The literature on NAD+ concentrates on its role as a metabolic cofactor and on how cellular levels change with age and across different physiological states in laboratory models. PubMed collects much of that literature, centered on redox biology, sirtuin activation, and PARP-mediated DNA repair.

None of that research is directed at human consumption or supports a therapeutic use outside the laboratory. Each study works with cellular or animal models under controlled experimental protocols, and the conclusions don't transfer directly to a person.

How is the purity of a NAD+ batch documented?

As with the peptides in the catalog, each batch of research material should arrive with its own analytical documentation. PeptoClinic's quality page explains how to read a certificate of analysis (COA): which laboratory signed it, what method it used, and how to confirm the report corresponds to the actual batch rather than a generic one copied off the internet. Before accepting any material — whether a dinucleotide like NAD+ or a peptide like BPC-157 or GHK-Cu — it's worth requesting that document and checking it.

NAD+ for research in Argentina

PeptoClinic Research Supply quotes research material, NAD+ included, for shipment to Argentina as part of its list of served destinations. Each shipment is prepared with the customs file corresponding to laboratory reference material, not a consumer product. For a full walkthrough of how the import process works and what documentation accompanies a shipment, PeptoClinic in Argentina details the process step by step.

Laboratory research use only

All material PeptoClinic supplies — NAD+ included — is provided strictly for Research Use Only (RUO): in vitro and laboratory studies. None of these compounds is a drug, a supplement, or a food, and none is approved or intended for human or veterinary consumption, diagnosis, or treatment of any condition. None of these statements has been evaluated by ANMAT, the FDA, or any equivalent authority. Anyone looking for a usage guideline, a dose, or an administration protocol won't find one here, because this business doesn't provide one.